Hillsdale Investment Management’s Guardant Health GH Stock Holding History

Hillsdale Investment Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$17.2M	Sell	114,384 -10,000	-8%	-$1.09M	0.39%	44
2026 Q1	$11.5M	Buy	124,384 +2,004	+2%	+$201K	0.31%	49
2025 Q4	$12.5M	Sell	122,380 -33,520	-22%	-$3M	0.35%	50
2025 Q3	$9.74M	Buy	155,900 +19,800	+15%	+$1.08M	0.29%	55
2025 Q2	$7.08M	Buy	+136,100	New	+$6.08M	0.26%	67
2024 Q1	–	Sell	-136,380	Closed	-$3.69M	–	626
2023 Q4	$3.69M	Sell	136,380 -9,720	-7%	-$255K	0.3%	132
2023 Q3	$4.33M	Buy	+146,100	New	+$5.14M	0.4%	75

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Hillsdale Investment Management's GH Position: Q2 2026 in Review

Hillsdale Investment Management reduced its Guardant Health (GH) stake by 8% in Q2 2026, selling an estimated $1.09M and leaving 114,384 shares worth $17.2M. The position accounts for 0.39% of the portfolio, ranked #44.

Hillsdale Investment Management first reported a position in GH in Q3 2023 and has held it in 7 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Hillsdale Investment Management held 114,384 shares of Guardant Health worth $17.2M as of Q2 2026.
Hillsdale Investment Management sold 10,000 Guardant Health shares in Q2 2026, an estimated $1.09M.
Guardant Health made up 0.39% of Hillsdale Investment Management's portfolio in Q2 2026, its #44 holding.
Hillsdale Investment Management first reported a position in Guardant Health in Q3 2023 and has held it in 7 quarters since.
600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Hillsdale Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.